Early research (Phase 1)Ended earlyNCT04800822What this trial is testingPF-07284892 in Participants With Advanced Solid TumorsWho this might be right forSolid Tumor Pfizer 53
Large-scale testing (Phase 3)Study completedNCT04649203What this trial is testingCytoflavin in the Treatment of Patients With Diabetic PolyneuropathyWho this might be right forDiabetic Neuropathies POLYSAN Scientific & Technological Pharmaceutical Company 216
Not applicableLooking for participantsNCT06377033What this trial is testingUsing the EHR to Advance Genomic Medicine Across a Diverse Health SystemWho this might be right forGenetic PredispositionParagangliomaPheochromocytoma+7 more University of Pennsylvania 1,000
Very early researchUnknownNCT03010241What this trial is testingThe Multi-Centric Clinical Study of Chinese Medicine Intervention on Diabetes Distal Symmetric Polyneuropathy.Who this might be right forType 2 Diabetes Mellitus Guang'anmen Hospital of China Academy of Chinese Medical Sciences 188
Large-scale testing (Phase 3)Study completedNCT01572727What this trial is testingThe Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K ActivationWho this might be right forBreast Cancer Novartis Pharmaceuticals 416
Early research (Phase 1)Study completedNCT02797847What this trial is testingA Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy SubjectsWho this might be right forTransthyretin-mediated Amyloidosis (ATTR Amyloidosis) Alnylam Pharmaceuticals 80
Testing effectiveness (Phase 2)Ended earlyNCT03685253What this trial is testingNicotinamide Riboside for Diabetic NeuropathyWho this might be right forDiabetic Neuropathy Peripheral University of Maryland, Baltimore 10
Large-scale testing (Phase 3)Study completedNCT01960348What this trial is testingAPOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated AmyloidosisWho this might be right forTTR-mediated AmyloidosisAmyloidosis, HereditaryAmyloid Neuropathies, Familial+3 more Alnylam Pharmaceuticals 225
Early research (Phase 1)Study completedNCT04035135What this trial is testingA Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)Who this might be right forGuillain-Barré Syndrome Annexon, Inc. 14
Large-scale testing (Phase 3)Study completedNCT05619328What this trial is testingA Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.Who this might be right forPeripheral Sensory Neuropathy of Different Etiologies Procter and Gamble 323
Large-scale testing (Phase 3)Study completedNCT02510261What this trial is testingThe Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)Who this might be right forAmyloidosis Alnylam Pharmaceuticals 211
Not applicableLooking for participantsNCT06052345What this trial is testingPaclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle OutcomesWho this might be right forBreast NeoplasmsBreast CancerEarly-stage Breast Cancer+5 more Theodoros Foukakis 100
Post-approval studies (Phase 4)Study completedNCT00162968What this trial is testingEscitalopram as a Treatment for Pain in PolyneuropathyWho this might be right forPainPolyneuropathies Odense University Hospital 50
Early research (Phase 1)Ended earlyNCT04330625What this trial is testingGlucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)Who this might be right forHyperglycemia Drug Induced Duke University 1
Testing effectiveness (Phase 2)Ended earlyNCT00756041What this trial is testingSafety Study of TAK-128 in Subjects With Diabetic Peripheral NeuropathyWho this might be right forDiabetic Neuropathies Takeda 221
Early research (Phase 1)Study completedNCT00570310What this trial is testingNeuropathic Pain Syndrome Patient Study (MK-0000-072)Who this might be right forNeuralgia, PostherpeticDiabetic NeuropathyPainful Small-Fiber Neuropathy+1 more Merck Sharp & Dohme LLC 104
Testing effectiveness (Phase 2)Study completedNCT00760955What this trial is testingEfficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral NeuropathyWho this might be right forDiabetic Neuropathies Takeda 338
Early research (Phase 1)WithdrawnNCT03773328What this trial is testingA Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)Who this might be right forGuillain-Barré Syndrome Cellenkos, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06798012What this trial is testingTAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Who this might be right forChronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Takeda 36
Testing effectiveness (Phase 2)Study completedNCT02595983What this trial is testingThe Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver TransplantWho this might be right forTransthyretin (TTR)-Mediated AmyloidosisFamilial Amyloidotic Polyneuropathy (FAP)ATTR Amyloidosis+1 more Alnylam Pharmaceuticals 12